OVERALL SAFETY AND TOLERABILITY OF RELAMORELIN IN ADULTS WITH DIABETIC GASTROPARESIS: ANALYSIS OF PHASE 2A AND PHASE 2B TRIAL DATA

Michael Camilleri  1     Anthony J. Lembo  2     Richard W McCallum  3     Stavros Tourkodimitris  4     Lara Kemps  4     Matthew Miller  4     Kirk Bertelsen  4     Alexandru Iacob  4     Dominic Lawrance  5    
1 Mayo Clinic,Rochester,United States
2 Harvard Medical School,Boston,United States
3 Texas Tech University Health Sciences Center,El Paso,United States
4 Allergan plc,Madison,United States
5 All

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing